To the Editors:
The study by Ugajin et al. 1 nicely evaluates the role of procalcitonin in differentiating community-acquired pneumonia (CAP) from pulmonary tuberculosis (PTB). They have further highlighted its prognostic value in PTB. Few aspects regarding this promising biomarker need to be discussed to understand its clinical …